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ABSTRACT

Here, we report two paired sets of an index wild-type Candida glabrata
bloodstream isolate and subsequent echinocandin-resistant FKS mutant. One paired set
exhibited a higher proportion of clumping cells and was more virulent in the invertebrate host Galleria mellonella than the other paired set. No virulence difference between
the paired index and FKS strains was observed. These ﬁndings imply a potential link of
clumping morphology with virulence in C. glabrata that is uncoupled from FKS-mediated
echinocandin resistance.

IMPORTANCE Candida glabrata is a leading cause of invasive candidiasis. In contrast

to other species, it has a high propensity for developing resistance to echinocandins,
which are the ﬁrst-line treatment. Unlike the dimorphic Candida albicans which can
grow invasive ﬁlamentous hyphae, C. glabrata lacks this ability. Here, we report a link
between virulence and clumping cell morphology in two different sets of clinical C. glabrata strains obtained from patients failing echinocandin therapy. One set of paired
strains (echinocandin-susceptible and subsequent resistant mutant) had a high proportion of clumping cells in the population and were signiﬁcantly more virulent than
another set which had fewer clumping cells. Additionally, we corroborate that echinocandin resistance does not impart a signiﬁcant ﬁtness cost. Our ﬁndings suggest that
clumping morphology may be an important but previously underestimated virulence
factor for C. glabrata and also aid our understand for the high prevalence of resistance
observed in this species.
KEYWORDS Candida glabrata, yeast, echinocandin resistance, morphology, chitin,

virulence

D

espite the widespread use of echinocandins, acquired resistance remains uncommon in most Candida species (;3%) (1), whereas a relatively high rate of Candida
glabrata isolates (.10%) display echinocandin resistance (2–5). The mechanism underlying the propensity of C. glabrata to develop resistance remains unclear. With limited
therapeutic options, understanding the biological and morphological alterations associated
with C. glabrata echinocandin resistance and their link with pathogenicity is critical.
Large-cell morphologies of fungal pathogens, such as the aggregative phenotype
of Candida auris, have been associated with reduced in vivo virulence (6). Here, we
describe a large clump-like morphology (cells with $3 buds) in clinical C. glabrata
strains (a wild-type [WT] strain and its echinocandin-resistant FKS mutant) grown in
RPMI 1640 liquid medium (RPMI) and study its link with echinocandin resistance and in
vivo virulence. Speciﬁcally, we compared the virulence potential of isolates exhibiting
high and low proportions of clump-like cells and studied the impact of echinocandin
resistance on the growth rate, cell wall chitin content, morphology, and virulence in
two paired index WT strains (A1 and B1) and their isogeneic echinocandin-resistant
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TABLE 1 In vitro features of two pairs of clinical C. glabrata strains
Area of cells with ‡3 buds (mm2)
Strain
A1
A2
B1
B2
aCell

Patient
A
A
B
B

FKS genotype
WT
FKS2-S663P
WT
FKS2-S663P

Count
918
1015
1816
2622

Mean ± SD
66 6 38
67 6 39
77 6 32
85 6 47

Min.–max.
37–892
32–831
34–469
36–884

Median
60
61
70
73

Growth rate (h21)
0.45 6 0.02
0.46 6 0.01
0.39 6 0.02
0.36 6 0.02

Doubling time (h)
1.55 6 0.06
1.50 6 0.04
1.80 6 0.08
1.91 6 0.11

Chitina (AU)
347 6 154
445 6 162
256 6 97
417 6 165

wall chitin was analyzed via indirectly measuring the ﬂuorescence intensity of calcoﬂuor white (CFW)-stained C. glabrata, with arbitrary units (AU).

FKS mutant strains (A2 and B2). Both sets were isolated from two unique hospitalized
patients (A and B) according to an institutional review board (IRB)-approved protocol
(Committee for the Protection of Human Subjects [CPHS] number 00000044). Both
patients had persistent candidemia despite at least 5 days of micafungin (MFG) treatment. The index-WT strains and MFG-resistant strains were isolated from the index
blood culture and from a positive blood culture after MFG, respectively.
The MICs of MFG and other antifungals for the WT and resistant strains are summarized in Table S1 in the supplemental material. An analysis of whole-genome
shotgun sequencing data showed that paired strains were highly related, with signiﬁcantly fewer single nucleotide polymorphism (SNP) differences observed
between intrapatient (69 to 84 SNPs) versus interpatient (4,580 to 4,644 SNPs) isolates. Both MFG-resistant isolates harbored an FKS2 S663P point mutation as
described previously (7). Key features of the two pairs are shown in Table 1. Set A
strains (A1 and A2) grew faster in RPMI at 37°C than set B strains (B1 and B2)
(Student’s t test, df = 10, P , 0.00005), whereas growth rates were not signiﬁcantly
different between the paired strains from each patient (Student’s t test, df = 4,
P . 0.05). The cell wall chitin content was analyzed using a previously described
calcoﬂuor white (CFW) staining assay with slight modiﬁcations (8). The FKS mutants
had a higher cell wall chitin content than their corresponding WT strains (A1 versus
A2, countA1 = 2,247, countA2= 2,317, Mann-Whitney U test, P , 1027; B1 versus B2,
countB1 = 2,098, countB2= 1,586, Mann-Whitney U test, P , 1027), and the observed
increase in chitin content could be a compensatory effect of the reduced biosynthesis of b -1,3-glucan in the FKS mutants (9).
Using imaging ﬂow cytometry analysis (FlowSight, EMD Millipore-Amins, Seattle,
WA), we observed that all C. glabrata strains commonly grew in RPMI mainly as singleand double-bud cells (Fig. 1A). However, the B set strains had a signiﬁcantly higher proportion of clumped cells (mean, 22.7% 6 5.6%) than the A set strains (mean: 9.9% 6
3.0%) (Student’s t test, df = 6, P , 0.01) (Fig. 1B). In addition, the median area of clumping cells from the B set strains (71 6 2.9 m m2) was signiﬁcantly larger than that
(60.5 6 1.3 m m2) of the set A strains (Student’s t test, df = 6, P , 0.001). There was no
signiﬁcant difference in the proportion (or the median area) of clumping cells between
the paired strains from the same patient (Student’s t test, df = 2, P . 0.05). In the
sorted clumping-cell populations, the median areas of clumping cells in isolates B1
and B2 were similar (70 versus 73 m m2) (Table 1). This result suggests that FKS-mediated echinocandin resistance had a minimal impact on the proportion and size of
clumping cells in these two sets of C. glabrata strains.
We subsequently compared the virulence of the two sets of strains using the invertebrate greater wax moth larva (Galleria mellonella) model as described previously with
slight modiﬁcation (10). Brieﬂy, larvae at the ﬁnal instar stage (n = 16,200 to 250 mg of
body weight) were injected with 107 cells of each strain suspended in phosphate-buffered saline (PBS), and mortality was monitored for 5 days. Five-day survival rates of larvae infected with strains B1 and B2 were 0%, while 21% to 29% of the larvae infected
with strains A1 and A2, respectively, survived until day 5 (Fig. 1C) (P , 0.05, log-rank
test). In contrast, larvae infected with paired WT and FKS mutant strains did not exhibit
signiﬁcantly different 5-day survival rates (P . 0.05, log-rank test), suggesting that
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FIG 1 Summary of experimental ﬁndings. (A) Representative images of unbudded C. glabrata cells and yeast cells with
different numbers of buds (1, 2, and $3) obtained using imaging ﬂow cytometry. The yeast cells were stained with
calcoﬂuor white (CFW). The brightﬁeld (BF), CFW, and BF1CFW represent the yeast BF image collected in channel 1,
the CFW ﬂuorescent image collected in channel 7, and the composite of BF and CFW ﬂuorescent merged images,
respectively. (B) Proportion of clumping cells for each C. glabrata strain; each measurement was performed in
duplicate. (C) Survival curves of Galleria mellonella infected with each C. glabrata strain.

acquired echinocandin resistance had a minimal impact on the virulence of C. glabrata
in the G. mellonella model.
Taken together, our ﬁndings highlight the phenotypic diversity of C. glabrata clinical strains in terms of growth rates, morphology, chitin contents, and virulence but
also suggest a potential link of the clump-like morphology and virulence which are
uncoupled from echinocandin resistance. The clump-like morphology described
here appeared to result from an incomplete separation of daughter cells. Prior
research in the phylogenetically related yeast Saccharomyces cerevisiae suggested
that clumping hampered cellular growth in the absence of stress but was advantageous in the presence of stress (11). Indeed, despite their growth rate disadvantage
(Table 1), the set B strains, which had had a more prominent clumping phenotype,
were more virulent in G. mellonella. Thus, the clump-like morphology of C. glabrata
could have physiological relevance in adverse environments, such as encounters
with host defenses.
The survival advantage of strains growing high proportions of clump-like cells
might be explained partially by their improved ability to evade phagocytosis due
to the size effect. Previous studies have demonstrated that both the genetic mutation in the chitin synthase gene CHS2 and the deletion of the transcription factor
gene ACE2 in C. glabrata resulted in the clumping growth and increased virulence
in the corresponding mutants (Evo and Dace2, respectively) (12, 13). Additionally,
deletion of the a-(1,2)-mannosyltransferase gene MNN2 resulted in the formation
Volume 10 Issue 1 e01837-21
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of small cellular aggregates and the increased virulence (14). We detected the single-nucleotide polymorphisms (SNPs) in these genes (CHS2 and ACE2) between
two sets of strains (A1 and A2 versus B1 and B2) (see Table S2 in the supplemental
material). It would be warranted for future researchers to clarify whether the
observed clumping phenotype and virulence are associated with these genes in C.
glabrata.
As our study was based on only two sets of C. glabrata isolates, there is a possibility of
confounding effects of interstrain variances that are not linked to the clumping phenotype.
Further comparative studies using more sets of strains and different in vivo platforms
would be warranted in order to corroborate the association of clumping morphology with
in vivo ﬁtness of C. glabrata. In addition, we observed and studied the clump-like morphology of C. glabrata grown in RPMI 1640 medium in vitro. Whether the clumping phenotype
is found in other growth media and, most importantly, is retained in vivo should be
addressed in future studies.
Despite these limitations, we describe a multibudded, clump-like phenotype of C.
glabrata that might be linked to enhanced ﬁtness and is uncoupled from acquired
FKS-mediated echinocandin resistance, contrasting the signiﬁcant ﬁtness cost of echinocandin resistance observed in C. albicans (15). Such diverging ﬁtness costs between
C. glabrata and C. albicans may explain the disparate incidence rates of echinocandin
resistance observed between these species.
Data availability. The project has been deposited in GenBank under the BioProject
numbers PRJNA795464 and PRJNA795468. Accession numbers associated with the whole
genome sequences of the isolates were as follows, JAKFQR000000000 (isolate A1),
JAKFQU000000000 (isolate A2), JAKFQT000000000 (isolate B1), and JAKFQS000000000
(isolate B2).
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